Determination of Mizolastine in pharmaceutical formulations

被引:0
|
作者
Sreelakshmi, A. [1 ]
Rao, G. Devala [2 ]
Babu, G. Sudhakara Sai [2 ]
机构
[1] Montessori Mahila Kalasala, Dept Biotechnol, Vijaywada 520010, India
[2] KVSR Siddhartha Coll Pharmaceut Sci, Vijaywada 520010, India
关键词
Mizolastine; Spectrophotometric; MZL;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mizolastine is an antihistamine drug. Two simple, sensitive and accurate spectrophotometric methods have been developed for the determination of Mizolastine in pure state and in its pharmaceutical formulations. The developed Method A is based on the formation of picrate salt between picric acid and free base of Mizolastine and it shows maximum absorption at lambda(max) 400 nm and Linearity in the range of 3-15 mu g/mL. Method B involves reaction between free base of Mizolastine and chloranilic acid. The developed chromogen in Method B shows maximum absorption at lambda(max) 530 nm and Linearity in the range of 50- 250 mu g/mL. The results obtained were statistically evaluated and were found to be accurate and reproducible.
引用
收藏
页码:239 / 242
页数:4
相关论文
共 50 条
  • [21] Spectrophotometric determination of dopamine in pharmaceutical formulations
    N. Rami Reddy
    G. Sreedevi
    K. Prabhavathi
    I. E. Chakravarthy
    Journal of Analytical Chemistry, 2005, 60 : 252 - 253
  • [22] Spectrophotometric determination of citalopram in pharmaceutical formulations
    Raza, Asad
    Ansari, Tariq Mahmood
    Niazi, Shahida Begum
    JOURNAL OF THE CHEMICAL SOCIETY OF PAKISTAN, 2008, 30 (02): : 241 - 245
  • [23] SPECTROPHOTOMETRIC DETERMINATION OF NIZATIDINE IN PHARMACEUTICAL FORMULATIONS
    VLADIMIROV, S
    BRBORIC, J
    SVONJA, M
    ZIVANOVSTAKIC, D
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 13 (07) : 933 - 936
  • [24] Spectrophotometric determination of flurazepam in pharmaceutical formulations
    Popovic, G. V.
    Pfendt, L. B.
    Analusis, 24 (06):
  • [25] Voltammetric determination of cilazapril in pharmaceutical formulations
    Tamer, U
    Özçiçek, NP
    Atay, O
    Yildiz, A
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 29 (1-2) : 43 - 50
  • [26] Spectrofluorometric determination of ibuprofen in pharmaceutical formulations
    Damiani, PC
    Bearzotti, M
    Cabezón, MA
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 25 (3-4) : 679 - 683
  • [27] Spectrophotometric determination of dopamine in pharmaceutical formulations
    Reddy, NR
    Sreedevi, G
    Prabhavathi, K
    Chakravarthy, IE
    JOURNAL OF ANALYTICAL CHEMISTRY, 2005, 60 (03) : 252 - 253
  • [28] COLORIMETRIC DETERMINATION OF ALUMINUM IN PHARMACEUTICAL FORMULATIONS
    RAGGI, MA
    CAVRINI, V
    DIPIETRA, AM
    PHARMACEUTICA ACTA HELVETIAE, 1984, 59 (08): : 225 - 227
  • [29] Spectrophotometric determination of midazolam in pharmaceutical formulations
    Pfendt, LB
    Popovic, GV
    Supancic, SI
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 13 (12) : 1551 - 1553
  • [30] Potentiometric determination of captopril in pharmaceutical formulations
    Ribeiro, PRD
    Santini, AO
    Pezza, HR
    Pezza, L
    ECLETICA QUIMICA, 2003, 28 (01): : 39 - 44